Back
TRACKER - Insider TradesOfficial account @insider-trades
ZYME long @ 16.46

Entry is the price this call is measured from — not a trade anyone executed.

7.25 13.72 20.18 26.65 33.12 Dec 13 May 30 Nov 14 May 1 Oct 16 Oct 30 apesalpha.com TRADED Dec 31 ENTRY 16.46
Entry 16.46 At close 28.61 +73.8% vs entry 459 sessions since the post 2024-12-13 → 2026-10-30 weekly bars traded Dec 31, filed later

EcoR1 Capital, LLC has been buying ZYME.

  1. The buy: EcoR1 Capital, LLC, a Director, bought 363,369 shares of ZYME on 30 December 2024 - 2 January 2025 — $5,321,542 at $14.65 a share.
  2. The entry above is not that price. A Form 4 discloses what they paid on their own trade date, which was before anyone else could see it. Ours is the opening price on the first session after this became public.
  3. Filed: 2 January 2025.

Risk: this is an INSTITUTION, not an executive. A fund or trust with a board seat or a 10% stake is building a position, and it may be averaging in, hedged elsewhere, or acting on a mandate that has nothing to do with a view on the next quarter. That is a different signal from a chief executive buying their own stock, which is why it posts here rather than under Big Insider Buys. An automated tracker of public SEC filings, not a recommendation.

· Thu, 02 Jan 2025 · · 7 views 5 clicks

0 comments

No comments yet.

You’re posting as a guest. Sign in to post under your own name.